BS

Tax Strategist Brian Charbonnier Joins Andersen's Commercial Practice in Los Angeles

Retrieved on: 
Monday, October 2, 2023
Accounting, Professional Services, Brian Andersen, Duquesne University, Thomas R. Kline School of Law of Duquesne University, BS, University, Unfair Commercial Practices Directive 2005, EY, Business, Joseph M. Katz Graduate School of Business, MBA, The Beachbody Company, Andersen Tax, Mattel, Inc. v. MCA Records, Inc., Joseph, JD, Andersen Global, Thomas, City, Office, Management, Andersen, Finance, Boston College

Andersen is pleased to welcome Brian Charbonnier to its Commercial Practice in Los Angeles.

Key Points: 
  • Andersen is pleased to welcome Brian Charbonnier to its Commercial Practice in Los Angeles.
  • Brian has consistently demonstrated a forward-thinking approach to tax strategy, showcasing his ability to align intricate tax planning with broader business objectives.
  • His visionary mindset and adeptness at identifying groundbreaking solutions have set him apart as a leading strategist in the tax industry.
  • With Brian Charbonnier on board, Andersen's Commercial Practice is poised to continue delivering innovative tax solutions that drive success for its diverse clientele.

DELPHON ANNOUNCES APPOINTMENT OF JERRY BROZ, PHD TO VICE PRESIDENT, STRATEGIC MARKETING & BUSINESS DEVELOPMENT

Retrieved on: 
Monday, October 2, 2023
SSA Global Technologies, Semiconductor, Business development, BS, University, Mathematics, Electronics, System, Mechanical engineering, Business, Multimedia, Doctor of Philosophy, MS, University of Colorado Boulder, IEEE, Publication, Texas Instruments, Education minister, Japan, Aerospace engineering, Applied mathematics, SR, Senior Member, Technical, Management

HAYWARD, Calif. , Oct. 2, 2023 /PRNewswire/ -- Delphon, a worldwide provider of engineered polymer and adhesive products for the semiconductor, photonics, medical and electronics industries, today announced the appointment of Jerry Broz, PhD as Vice President, Strategic Marketing & Business Development.

Key Points: 
  • HAYWARD, Calif. , Oct. 2, 2023 /PRNewswire/ -- Delphon, a worldwide provider of engineered polymer and adhesive products for the semiconductor, photonics, medical and electronics industries, today announced the appointment of Jerry Broz, PhD as Vice President, Strategic Marketing & Business Development.
  • He will also be responsible for leading Delphon's overall business development strategy, focusing on growing market share and revenue in the semiconductor, optoelectronics, medical, defense and aerospace industries.
  • "I am excited to welcome Jerry as the VP, Business Development," says Joe Montano, Delphon President and CEO.
  • Delphon, specializes in polymer and adhesive materials and is known for solving complex product development and manufacturing challenges.

NAVC and MentorVet Partner To Provide Veterinary Nurses/Technicians Access to New Approach to Mentorship

Retrieved on: 
Thursday, September 28, 2023
Partnership, BS, Education, Veterinary medicine, Research, Mentorship, MS, Schering-Plough, CQD, Hive, Nursing, Risk, American Veterinary Medical Association, Mental health, CVT, DVM

ORLANDO, Fla., Sept. 28, 2023 /PRNewswire/ -- The North American Veterinary Community (NAVC) announces its support of MentorVet Tech, a new program created by MentorVet that is redefining veterinary mentorship with a holistic approach to helping veterinary nurses/technicians thrive in every aspect of their career. MentorVet and the NAVC are partnering to offer an extension of the MentorVet Tech program to veterinary nurses and technicians with multiple flash mentorship sessions. These interactive 90-minute sessions will be provided for no additional cost during NAVC's HiVE Vet Nurse + Tech event October 16-18 in Austin, TX, and facilitated by the MentorVet Team.

Key Points: 
  • MentorVet and the NAVC are partnering to offer an extension of the MentorVet Tech program to veterinary nurses and technicians with multiple flash mentorship sessions.
  • "The NAVC is pleased to partner with MentorVet to help reach, recruit, and engage veterinary nurses and technicians to be part of this program," said NAVC CEO, Gene O'Neill.
  • "The NAVC is pleased to partner with MentorVet to help reach, recruit, and engage veterinary nurses and technicians to be part of this program," said NAVC CEO, Gene O'Neill.
  • MentorVet Tech was developed by Addie Reinhard, DVM, MS, mental health professionals, and expert veterinary technicians including MentorVet Tech program director, Alyssa Mages, BS, CVT.

American Rare Earths Provides Update on US Management

Retrieved on: 
Thursday, September 28, 2023
Sanderson, BS, Advisory board, University of Colorado Denver Business School, University, College, General counsel, Evers, Head, Policy, Erivan K. Haub School of Business, ASX, Alumni association, Certified Public Accountant, Almquist, Government, Accounting, ADR Institute of Alberta, Business administration, CO, Canadian American Business Council, Rocky Mountains, Philippine Senate Committee on Environment, Natural Resources and Climate Change, ARR, Mining, Natural Resources, ESG, Northwestern Alumni Association, Management, Environment

Ms. Sanderson will transition out of her executive role as President of North America effective October 1, 2023, and will continue to be a non-executive director of the American Rare Earths Board.

Key Points: 
  • Ms. Sanderson will transition out of her executive role as President of North America effective October 1, 2023, and will continue to be a non-executive director of the American Rare Earths Board.
  • In addition, the Company appointed Joe Evers as General Counsel and Jennifer Almquist as Head of Investor Relations, effective immediately.
  • “I am pleased to welcome Joe and Jennifer to the American Rare Earths team,” said Donald Swartz, Chief Executive Officer of ARR.
  • “Their experience and expertise will be invaluable to us as we build up our US presence and continue to execute on our strategic plan.”
    This market announcement has been authorized for release to the market by the CEO of American Rare Earths.

Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer

Retrieved on: 
Wednesday, September 27, 2023
Rachel Haurwitz, CRISPR, BS, Reindeer, Culture, Doctor of Philosophy, Acquisition, Patient, Bone marrow, Growth, Heidrick, Genome, Heidrick & Struggles, Management

BERKELEY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Reigin Zawadzki to the newly created position of chief people officer.

Key Points: 
  • BERKELEY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Reigin Zawadzki to the newly created position of chief people officer.
  • Ms. Zawadzki brings over 20 years of experience leading human resources in the biotechnology industry.
  • She will lead Caribou’s people strategy and report to Rachel Haurwitz, PhD, president and chief executive officer.
  • With Caribou now established as a clinical-stage company, we next aim to position our organization for future commercialization, and we are delighted to welcome Reigin as our first CPO.”
    “I am excited to join Caribou, a CRISPR genome editing pioneer and a leader in the allogeneic cell therapy field,” said Reigin Zawadzki, Caribou’s chief people officer.

Forcefield Therapeutics appoints John Tsai MD as Chief Executive Officer

Retrieved on: 
Wednesday, September 27, 2023
Heart, Amgen, BS, University, Cell death, Therapy, MI, Myocardial infarction, Heart failure, Quality of life, Electrical engineering, Panasonic Executive Partner, CMO, Washington University in St. Louis, Cardiovascular disease, Force field, Novartis, Patient, Risk, University of Louisville School of Medicine, Reperfusion, Mouse, Death, Electricity, Pharmaceutical industry, Syncona

Heart disease continues to be the number one cause of death worldwide, with no currently approved treatments to prevent the death of heart cells following a heart attack

Key Points: 
  • Heart disease continues to be the number one cause of death worldwide, with no currently approved treatments to prevent the death of heart cells following a heart attack
    London UK, 27 September 2023 – Forcefield Therapeutics (“Forcefield Tx”) Ltd, a pioneer of best-in-class therapeutics to retain heart function via protection of cardiomyocytes, today announced it has appointed John Tsai MD, Executive Partner at Syncona and most recently President, Global Drug Development and Chief Medical Officer at Novartis, as Chief Executive Officer, effective immediately.
  • John brings over 20 years’ experience in global pharmaceuticals with a proven track record in leading transformational organisational growth and strategy.
  • John holds a BS in Electrical Engineering from Washington University in St. Louis and M.D.
  • John Tsai MD, Chief Executive Officer of Forcefield Therapeutics, commented: “Despite advancements in health care, patients still have a 50% chance of death after an acute heart attack.

DIVERSIFIED SEARCH GROUP PROMOTES LAUREN E. SMITH TO CO-LEAD FIRM'S BOARD AND GOVERNANCE PRACTICE

Retrieved on: 
Tuesday, September 26, 2023
Thunderbird School of Global Management, BS, Face, National Association of Corporate Directors, Pennsylvania State University, Smith, MBA, Lauren, Westinghouse Electric Corporation, NACD, Growth, National Association, Thunderbird, Microsoft Corp. v. Motorola Inc., Management

Philadelphia, PA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Diversified Search Group, one of the nation’s top ten executive search firms, announced today that Lauren E. Smith will become Co-Head of the firm’s board and governance practice to expand the firm’s impact in the boardroom.

Key Points: 
  • Philadelphia, PA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Diversified Search Group, one of the nation’s top ten executive search firms, announced today that Lauren E. Smith will become Co-Head of the firm’s board and governance practice to expand the firm’s impact in the boardroom.
  • Deeply committed to strong corporate governance and board composition, she is the current Chair, Nominating & Governance, and past President, NACD Florida Chapter and a NACD Certified Director.
  • Smith joined Diversified Search Group in 2008 as Managing Director and has recruited senior executives from a broad range of industries for C-Suite and boardroom positions.
  • Judith von Seldeneck, Founder and Chair of Diversified Search said, “Lauren has been instrumental in contributing to the growth of our board practice over the last decade.

Inspire Medical Systems, Inc. Announces Events at International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings

Retrieved on: 
Tuesday, September 26, 2023
Inspiration, BS, American Academy of Otolaryngology–Head and Neck Surgery, American Academy, ISSS, OSA, Down syndrome, Organization, Otorhinolaryngology, Insomnia, Patient, Westin Hotels & Resorts, Physician, MCC, BMI, Sleep, Obstructive sleep apnea, NYSE, Pharmaceutical industry, Medical imaging, MD

MINNEAPOLIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today key events at the International Surgical Sleep Society (ISSS) and American Academy of Otolaryngology (AAO-HNSF) meetings in Nashville, TN, September 29 through October 4.

Key Points: 
  • MINNEAPOLIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today key events at the International Surgical Sleep Society (ISSS) and American Academy of Otolaryngology (AAO-HNSF) meetings in Nashville, TN, September 29 through October 4.
  • “We look forward to participating in ISSS and AAO-HNSF to highlight our Inspire technology platform and share clinical data demonstrating the real-world efficacy of our therapy,” said Tim Herbert, President and CEO.
  • In the scientific sessions, Inspire will be featured throughout the meetings in panel discussions, oral abstracts, and posters presented by leading otolaryngologists and sleep surgeons.
  • October 1, 1:00 pm CT in MCC 207CD
    ADHERE registry update: Relationship of insomnia symptoms and outcomes after hypoglossal nerve stimulation.

Ontada Names Christine Davis Its New President

Retrieved on: 
Monday, September 25, 2023
Oncology, Health, Health Technology, Clinical Trials, Pharmaceutical, Biotechnology, BS, Drug development, Therapy, Cerner Enviza, McKesson Corporation, Cancer, Cerner, Kantar, Biochemistry, Syracuse University, Patient, Growth, Commercial, Pharmaceutical industry, Nursing, Nutrition, Northeastern University

Ontada® , a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Christine Davis as its new president.

Key Points: 
  • Ontada® , a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Christine Davis as its new president.
  • With more than 25 years of experience in the life sciences industry, Davis possesses an impressive background in oncology research and real-world data.
  • “Christine has a strong track record of driving significant business growth and transformation,” said Kirk Kaminsky, president of Pharmaceutical Solutions and Services at McKesson.
  • “With the support of McKesson and the strength of Ontada, I see so much opportunity to bring real and powerful impact to patient lives.”

EQS-News: Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.

Retrieved on: 
Monday, September 25, 2023
Invictus, 3M, Non-U.S. operators of the M60 Patton, BS, Senior, Denison University, Supervisory board, Boston, MBA, Medicine, Qiagen, CDMO, KCI, Acquisition, Patient, Indiana Wesleyan University, Executive Committee, Roche, Biology, Growth, S-1 Executive Committee, Management, Industrial design, Medicover Hospitals, Greater Boston

Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.

Key Points: 
  • Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.
  • Prior to joining Rentschler Biopharma, Mr. von Braunmuehl served as CEO of HMNC Brain Health in Munich, Germany, where he transformed a research-focused organization to a clinical-stage biopharma company.
  • Prof. Dr. Nikolaus F. Rentschler, Chairman of the Supervisory Board of Rentschler Biopharma SE, said: “I would like to warmly welcome Benedikt von Braunmuehl to Rentschler Biopharma.
  • Mr. von Braunmuehl is the perfect fit for leading Rentschler Biopharma, to continue transforming innovative ideas into life-saving biopharmaceuticals in the future.